Allergy: European Journal of Allergy and Clinical Immunology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The impact of type 2 immunity and allergic diseases in atherosclerosis
2022
-
Development and validation of combined symptom‐medication scores for allergic rhinitis*.
77:2147-2162.
2022
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities.
77:1667-1684.
2022
-
Comparison of rhinitis treatments using
MASK
‐air® data and considering the minimal important difference
2022
-
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air
®
real‐world data
2022
-
Group 2 innate lymphoid cells in patients with nonasthmatic eosinophilic bronchitis.
77:649-652.
2022
-
Local inflammation enables a basophil‐neuronal
circuITCH
in atopic dermatitis.
77:708-710.
2022
-
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence.
77:454-468.
2022
-
The food, the bug, and the ugly: A recipe for food‐induced gut pain.
77:334-336.
2022
-
Detecting immunoglobulins in processed sputa.
76:3798-3800.
2021
-
Notch4, uncovering an immunomodulator in allergic asthma.
76:3852-3854.
2021
-
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report.
76:3589-3612.
2021
-
Medical algorithms: Approach to adult asthma exacerbations.
76:3556-3559.
2021
-
Management of anaphylaxis due to COVID‐19 vaccines in the elderly.
76:2952-2964.
2021
-
Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”.
76:2663-2672.
2021
-
Effect of anti‐IL‐5 biologics on weight and body mass index.
76:2913-2916.
2021
-
Effect of intranasal corticosteroid treatment on allergen‐induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.
76:2797-2808.
2021
-
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA
2
LEN consensus.
76:2354-2366.
2021
-
Enlightening human B‐cell diversity.
76:2644-2646.
2021
-
Comparison of house dust mite sensitization profiles in allergic adults from Canada, Europe, South Africa and USA.
76:2177-2188.
2021
-
First contact: Serum amyloid A and pattern recognition in Th2 immunity.
76:2309-2311.
2021
-
IL‐13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat!.
76:1964-1966.
2021
-
Direct and indirect bronchoprovocation tests in dose‐response studies of inhaled corticosteroids: Past, present, and future directions.
76:1679-1692.
2021
-
Immunological changes in peripheral blood following nasal allergen challenge in subjects with allergic rhinitis pre‐ and post‐peptide immunotherapy: An open‐label clinical study.
76:1907-1911.
2021
-
The global burden of illness of peanut allergy: A comprehensive literature review.
76:1367-1384.
2021
-
Monitoring eosinophils to guide therapy with biologics in asthma: does the compartment matter?.
76:1294-1297.
2021
-
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020).
76:689-697.
2021
-
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19.
76:735-750.
2021
-
Dupilumab, severe asthma airway responses, and SARS‐CoV‐2 serology.
76:957-958.
2021
-
Modeling the conversion between specific IgE test platforms for nut allergens in children and adolescents.
76:831-841.
2021
-
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.
76:168-190.
2021
-
Asthma exacerbations on benralizumab are largely non‐eosinophilic.
76:375-379.
2021
-
EAACI Biologicals Guidelines—Recommendations for severe asthma.
76:14-44.
2021
-
Thinking small: Zinc sensing by the gut epithelium.
76:411-413.
2021
-
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2.
75:2503-2541.
2020
-
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI).
75:2445-2476.
2020
-
Single‐cell RNA analysis: Guiding the treatment of DiHS/DRESS.
75:2713-2715.
2020
-
Phenotype consensus is required to enable large‐scale genetic consortium studies of food allergy.
75:2383-2387.
2020
-
The neuroimmunological toll of nutrient absorption.
75:2415-2417.
2020
-
Exon 8
KIT
mutation and pulmonary eosinophilia.
75:2094-2096.
2020
-
Mining the infant gut microbiota for therapeutic targets against atopic disease.
75:2065-2068.
2020
-
Sputum and serum immunoglobulins in adult asthmatics with recurrent respiratory tract infections.
75:2105-2108.
2020
-
Cord blood hemopoietic cell receptor expression is associated with early life atopic risk and lung function.
75:1762-1765.
2020
-
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK‐air
®
App.
75:1672-1688.
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma.
75:1043-1057.
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma.
75:1023-1042.
2020
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma.
75:1058-1068.
2020
-
The presence of
Aspergillus fumigatus
in asthmatic airways is not clearly related to clinical disease severity.
75:1146-1154.
2020
-
Follicular T cells: From stability to failure.
75:1006-1007.
2020
-
New paradigm in asthma management: Switching between biologics!.
75:743-745.
2020
-
Drug‐induced IgG‐neutrophil‐mediated anaphylaxis in humans: Uncovered!.
75:484-485.
2020
-
Mechanisms and therapeutic strategies for non‐T2 asthma.
75:311-325.
2020
-
Extract and component‐specific sensitization patterns in Canadian moderate‐to‐severe preschool asthmatics.
74:2519-2521.
2019
-
2019 ARIA Care pathways for allergen immunotherapy.
74:2087-2102.
2019
-
Modulation of CRTh2 expression on allergen‐specific T cells following peptide immunotherapy.
74:2157-2166.
2019
-
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018.
74:2244-2248.
2019
-
Legends of allergy: Professor A. B. Kay.
74:1588-1590.
2019
-
ARIApharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”.
74:1219-1236.
2019
-
Effect of sex on group 2 innate lymphoid cells in the airways of mild and severe asthmatics.
74:1397-1400.
2019
-
Rapid quantification of sputum eosinophil peroxidase on a lateral flow test strip.
74:1176-1178.
2019
-
Much ado about Biologicals:
Highlights of the Master Class on Biologicals, Prague, 2018.
74:837-840.
2019
-
IgG1
+
B‐cell immunity predates IgE responses in epicutaneous sensitization to foods.
74:165-175.
2019
-
Human milk oligosaccharide profiles and food sensitization among infants in the
CHILD
Study.
73:2070-2073.
2018
-
Sputum cytology during late-phase responses to inhalation challenge with different allergens.
73:1470-1478.
2018
-
Perspectives in allergen immunotherapy: 2017 and beyond.
73:5-23.
2018
-
Vitamin D supplementation in primary allergy prevention: Systematic review of randomized and non‐randomized studies.
73:37-49.
2018
-
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement.
72:1297-1305.
2017
-
Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.
72:1035-1042.
2017
-
Novel approaches and perspectives in allergen immunotherapy.
72:1022-1034.
2017
-
A dual CysLT1/2antagonist attenuates allergen-induced airway responses in subjects with mild allergic asthma.
71:1721-1727.
2016
-
Global perceptions of food allergy thresholds in 16 countries.
71:1081-1085.
2016
-
Emotional and behavioral problems in adolescents and young adults with food allergy.
71:532-540.
2016
-
Histone deacetylase activity and recurrent bacterial bronchitis in severe eosinophilic asthma.
71:571-575.
2016
-
Nasal and pharyngeal eosinophil peroxidase levels in adults with poorly controlled asthma correlate with sputum eosinophilia.
71:567-570.
2016
-
Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity.
71:283-285.
2016
-
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
70:1372-1392.
2015
-
Treatment with anti-OX40L or anti-TSLP does not alter the frequency of T regulatory cells in allergic asthmatics.
70:1505-1508.
2015
-
Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy.
70:495-505.
2015
-
Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma.
70:302-309.
2015
-
Once‐daily fluticasone furoate 50 mcg in mild‐to‐moderate asthma: a 24‐week placebo‐controlled randomized trial.
69:1522-1530.
2014
-
Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure - challenges and actions to be taken.
69:978-982.
2014
-
EAACI position statement on asthma exacerbations and severe asthma.
68:1520-1531.
2013
-
Myeloid dendritic cells type 2 in allergic asthma.
68:1322-1326.
2013
-
Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.
68:n/a-n/a.
2013
-
Erratum.
67:712-712.
2012
-
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy.
67:217-226.
2012
-
Comparing school environments with and without legislation for the prevention and management of anaphylaxis.
67:131-137.
2012
-
Dose-response effects of TPI ASM8 in asthmatics after allergen.
66:1242-1248.
2011
-
Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.
66:1038-1046.
2011
-
Sputum inflammatory cells and allergen-induced airway responses in allergic asthmatic subjects.
66:1075-1080.
2011
-
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA2LEN statement.
66:765-774.
2011
-
Immunotherapy with peptides.
66:784-791.
2011
-
Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations.
66:588-595.
2011
-
Effect of asthma treatment on fitness, daily activity and body composition in children with asthma.
65:1464-1471.
2010
-
Geographical variations in the prevalence of atopic sensitization in six study sites across Canada.
65:1404-1413.
2010
-
Lung involvement in Churg-Strauss syndrome as related to the activity of the disease.
65:1484-1485.
2010
-
Development and implementation of guidelines in allergic rhinitis - an ARIA-GA2LEN paper.
65:1212-1221.
2010
-
Reply.
65:1337-1339.
2010
-
Management of anaphylaxis in primary care: Canadian expert consensus recommendations.
65:no-no.
2010
-
Heart involvement detected by magnetic resonance in a patient with Churg-Strauss syndrome, mimicking severe asthma exacerbation.
65:1063-1064.
2010
-
Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature.
65:435-444.
2010
-
Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009.
64:1-59.
2009
-
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper.
64:1737-1745.
2009
-
EAACI/GA
2
LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.
64:1417-1426.
2009
-
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria.
64:1427-1443.
2009
-
Efficacy of desloratadine in intermittent allergic rhinitis: a GA
2
LEN study.
64:1516-1523.
2009
-
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’.
64:969-977.
2009
-
Differential effects of skin nerves on allergic skin inflammation.
64:496-497.
2009
-
Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies.
64:1109-1116.
2009
-
Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions.
64:669-677.
2009
-
Allergic rhinitis management pocket reference 2008.
63:990-996.
2008
-
Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome.
63:949-950.
2008
-
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper.
63:842-853.
2008
-
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*.
63:8-160.
2008
-
Consensus statements, evidence-based medicine and guidelines in allergic diseases.
63:1-4.
2008
-
Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study.
63:103-111.
2008
-
Methodology for development of the Allergic Rhinitis and its Impact on Asthma Guideline 2008 update.
63:38-46.
2008
-
Circulating myeloid and plasmacytoid dendritic cells after allergen inhalation in asthmatic subjects.
62:1139-1145.
2007
-
The allergen bronchoprovocation model: an important tool for the investigation of new asthma anti-inflammatory therapies.
62:1101-1110.
2007
-
Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics.
62:495-503.
2007
-
Peptide immunotherapy for allergic diseases.
62:325-331.
2007
-
GINA guidelines on asthma and beyond.
62:102-112.
2007
-
Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
61:731-736.
2006
-
Anti-inflammatory effects of once daily low dose inhaled ciclesonide in mild to moderate asthmatic patients.
61:537-542.
2006
-
Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
60:330-337.
2005
-
Pharmacia Allergy Research Foundation and its Award for Young Scientists in Allergy Research.
60:269-270.
2005
-
The links between allergen skin test sensitivity, airway responsiveness and airway response to allergen.
60:56-59.
2005
-
Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36.
57:201-206.
2002
-
Selective upregulation of a functional beta7 integrin on differentiating eosinophils.
55:865-872.
2000
-
IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure.
55:749-756.
2000
-
Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis.
54:212-219.
1999
-
The clinical expression of allergy in the lungs.
54:7-14.
1999
-
The role of shock organs in influencing the clinical expression of allergy.
54:3-6.
1999
-
Hemopoietic progenitors and cytokines in allergic inflammation.
53:22-26.
1998
-
Retinoic acid modulation of induced basophil differentiation.
52:1201-1206.
1997
-
A comparison of the efficacy and safety of inhaled corticosteroids in asthma.
52:1-34.
1997
-
The role of the bone marrow in allergy and asthma.
51:141-148.
1996
-
Urticaria from allergy to a purified human anti-Rh antibody preparation.
50:981-983.
1995
-
Microenvironmental influences on inflammatory cell differentiation.
50:25-28.
1995
-
Comparative Therapeutic Studies with Tilavist.
50:23-29.
1995
-
CONSEQUENCES - QUALITY ASSURANCE AND SOCIOECONOMICS - DISCUSSION.
48:162-163.
1993
-
DEFINITION, PREVALENCE AND DIAGNOSIS - DISCUSSION.
48:22-23.
1993
-
EXAMPLES OF MONITORING OF INFLAMMATION IN ASTHMA - DISCUSSION.
48:110-111.
1993
-
EXAMPLES OF MONITORING OF INFLAMMATION IN ASTHMA - DISCUSSION.
48:143-145.
1993
-
Impact of monitoring inflammation on the management of adult asthmatic patients..
48:153-157.
1993
-
NEW POSSIBILITIES IN MONITORING INFLAMMATION IN ASTHMA - DISCUSSION.
48:84-86.
1993
-
PATHOPHYSIOLOGY-INFLAMMATION - DISCUSSION.
48:48-49.
1993
-
PATHOPHYSIOLOGY-INFLAMMATION - DISCUSSION.
48:62-64.
1993
-
The definition and diagnosis of asthma..
48:12-16.
1993
-
INTERNATIONAL CONSENSUS REPORT ON DIAGNOSIS AND MANAGEMENT OF ASTHMA.
47:R1-&.
1992
-
The increased number of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy-dependent.
45:370-374.
1990
-
Development and implementation of a nurse-led allergy clinic model in primary care: A feasibility trial
2020
-
Geographic variability of house dust mite sensitization profiles: Der p 7 and Der p 23 are major allergens among South African allergic patients
2020
-
Results of a randomized, double-blind, placebo-controlled, phase 2 study, investigating the safety and efficacy of anti-factor XIIa monoclonal antibody garadacimab (CSL312) for prophylaxis of HAE
2020
-
Suboptimal response to benralizumab is not associated with inadequate eosinophil suppression
2020
-
Comparison of responses to nasal and whole lung allergen challenges in mild allergic asthmatic subjects with allergic rhinitis
2019
-
Crustacean characterization: Identifying the seafood allergic patient, co-morbidities and associated atopic risk factors
2019
-
Dupilumab reduces oral corticosteroid (OCS) use and severe exacerbations, and improves FEV1 in OCS-dependent, severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps
2019
-
Oral immunotherapy for peanut allergy: A systematic review and meta-analysis
2019
-
Seizing the moment: Benefits of immediate in-office penicillin oral challenge in the management of suspected penicillin allergy
2019
-
The cannabinoid receptor agonist WIN55,212-2 impairs peanut-induced allergic features by promoting the generation of tolerogenic dendritic cells
2019
-
Benefits of a low fructose/FODMAP diet in suspected fructose intolerance: Follow up and natural history
2018
-
Food allergy or intolerance: Characterization of fructose intolerance (FI) in an allergy clinic
2018
-
Hereditary Angioedema Rapid Triage Tool (HAE-RT): Translating research into clinical practice
2018
-
When it's not just chronic urticaria Recognizing and diagnosing Schnitzler's syndrome
2018
-
Another brick in the wall: toward a national food allergy strategy for Canada
2017
-
FoxP3+regulatory B cells were higher in sputum and blood, but lower in bone marrow following whole lung allergen challenge in allergic asthmatics
2017
-
Global review of epinephrine availability and anaphylaxis management practices amongst patient organization countries
2017
-
Implementation of stock epinephrine (stock epi) program in malls and food service establishments: A pilot implementation study
2017
-
Sputum anti-neutrophil cytoplasmic antibodies in eosinophilic granulomatosis and polyangiitis patients with respiratory involvement
2017
-
Characterization of regulatory B cell phenotypes in the blood and bone marrow following allergen inhalation challenge in mild allergic asthmatics
2016
-
Food allergen labeling and purchasing habits in the US and Canada
2016
-
Global knowledge & perceptions of food allergy thresholds in 16 countries
2016
-
IgE plus B cells increase in the airways following whole lung allergen challenge in mild allergic asthmatics
2016
-
IgE plus memory B cells subsets are higher in the airways of mild allergic asthmatics compared to healthy controls
2016
-
Pathogenic sputum autoantibodies in eosinophilic severe asthma: a novel autoimmune endotype
2016
-
RNA-seq transcriptome analysis of human allergen-specific T cells suggests a role for IL-8 downregulation and modulation of allergic inflammatory cells as one of several potential mechanisms of action of intradermal immunotherapy with Fel d 1 synthetic peptides
2016
-
The relationship between regulatory B cells and regulatory T cells in the blood and airways of mild allergic asthmatics
2016
-
Comparison of the treatment effect of house dust mite synthetic peptide immuno-regulatory epitopes in the environmental exposure chamber and field setting two years after a short course of treatment
2015
-
Mapping the local inflammatory cytokine secretion following a cumulative allergen dose using the Allergic Rhinitis Clinical Investigator Collaborative Nasal Allergen Challenge model
2015
-
Persistent treatment effect with grass synthetic peptide immuno-regulatory epitopes (Grass-SPIRE) on grass allergy symptoms in the environmental exposure unit after a third season of natural exposure
2015
-
Whole blood immune transcriptome profiling reveals systemic pathways associated with the mechanism of action of cat-synthetic peptide immunoregulatory epitopes
2015
-
A short course of synthetic peptide immuno-regulatory epitopes derived from grass allergens leads to a reduction in grass allergy symptoms
2014
-
Blood-based molecular biomarkers of allergen-induced early and late asthmatic responses
2014
-
Exploring origins of asthma and allergy: early results from the Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study
2014
-
Four doses of Der p derived synthetic peptide immuno-regulatory epitopes over 3 months results in a persistent treatment effect at 1 year on symptoms of House Dust Mite allergy
2014
-
Intracellular IL-1 alpha modulates peanut-induced anaphylaxis in a model of skin sensitisation
2014
-
Myeloid dendritic cells type 2 in allergic asthma
2013
-
A pilot study assessing adequacy of epinephrine autoinjector needle length to deliver epinephrine intramuscularly in adult patients with food and venom allergy
2013
-
Cat-PAD demonstrates sustained, consistent treatment effect on allergic rhinoconjunctivitis in individual catallergic patients 1 and 2 years after four intradermal injections
2013
-
Current practice with self-administration in the management of hereditary angioedema: the results of a survey
2013
-
Eosinophil/basophil (Eo/B) progenitors in cord blood (CB) predict respiratory outcomes in early infancy
2013
-
The Canadian allergy, genes and environment network of centres of excellence: AllerGen
2013
-
Total nasal symptom scores are reduced in an EEC model of cat allergy two years after administration of four doses of Cat-PAD
2013
-
Immunotherapy in Canada: perspectives of trainees on their current experience and the immunotherapy training manual
2012
-
Persistent treatment effect on ocular and nasal symptoms of cat allergy 1 year after four doses of Fel d 1 peptide immunotherapy
2012
-
Safety and efficacy of Fel d 1 derived peptide immunotherapy in a double-blind, placebo-controlled environmental exposure chamber study
2012
-
CCR4-acting chemokines contribute to tissue eosinophilia in Churg-Strauss syndrome
2011
-
Efficacy and safety of fluticasone furoate nasal spray in adult and adolescent subjects with uncomplicated acute rhinosinusitis
2011
-
Imbalance between Th17 and FoxP3+regulatory T-lymphocytes in Churg-Strauss syndrome
2011
-
Peculiarities of eicosanoid profile in exhaled breath condensates from patients with Churg-Strauss syndrome
2011
-
Case report of recurrent throat swelling due to hereditary angioedema despite prophylaxis treated with icatibant
2010
-
Consistency of effect of fluticasone furoate nasal spray on nasal and ocular symptoms of seasonal allergic rhinitis
2009
-
Digestibility and allergenicity of native and glycosylated egg white chicken lysozyme
2009
-
Fluticasone furoate nasal spray improves the individual nasal symptoms (rhinorrhoea, nasal congestion, nasal itching, sneezing) of seasonal allergic rhinitis across four studies
2009
-
Immunological mechanism of peptide-based immunotherapy in a murine model of acute house dust mite exposure
2009
-
Immunoreactivity of native and processed egg white chicken ovomucoid after gastroduodenal digestion
2009
-
Quality of life benefits for patients with seasonal grass pollen-allergic rhinoconjunctivitis receiving ultra short course subcutaneous immunotherapy (uSCIT) with MPL adjuvant
2009
-
The effect of C5 inhibition by eculizumab on allergen-induced asthmatic responses
2009
-
The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma
2008
-
Burden of allergic rhinitis amongst primary care practitioners and its impact on patient management
2008
-
Desloratadine significantly reduces nasal congestion and other individual symptoms scores in subjects with intermittent allergic rhinitis: The ACCEPT1 Study in collaboration with GA(2)LEN
2008
-
Comparative long-term efficacy of ciclesonide versus a fixed combination of fluticasone propionate and salmeterol in mild persistent asthma
2007
-
Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma
2007
-
The development of serum IgE test panels for use by Canadian primary care physicians
2007
-
Pharmacologic modulation of airway inflammation
1998
-
Impact of monitoring inflammation on the management of adult asthmatic patients
1993
-
The definition and diagnosis of asthma
1993
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)